caris life sciences ipo nasdaq - Search News

News

IPO, Caris and Life Sciences

Fast Company · 11h

Caris Life Sciences IPO: All eyes on the stock price today as the AI cancer care firm makes its Nasdaq debut

The cancer diagnostics and treatment company priced above its previously planned range and might signal a renewed appetite for biotech IPOs.

Seeking Alpha on MSN · 16h

Cancer diagnostics firm Caris prices IPO at $21 per share

Caris Life Sciences (NASDAQ:CAI) is scheduled to make its trading debut on Wednesday on the Nasdaq after the Irving, Texas-based cancer diagnostics company priced its initial public offering at $21.00 per share,

The Dallas Morning News · 13h

Irving-based Caris Life Sciences raises $494 million in IPO

Caris Life Sciences Inc., a health-care company that uses technology to help diagnose and treat cancer, raised $494 million in a US initial public

11h

DFW's newest public co. raises $494 million in IPO

The biotech firm filed its IPO paperwork May 23 in a bid to boost its finances, noting there was "substantial doubt" about ...

Caris swells its planned IPO, seeking $5.7bn valuation

The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results